Recruiting at 3 sites No phase HIV Prevention

Clinical trial for HIV Prevention

Official title California MEPS Hub

ClinicalTrials.gov ID: NCT07433985

What this study is testing

What it's testing
The study wants to see if the MEPS program can be adapted for different community sites and whether it helps participants get more HIV testing, start and stay on PrEP, and use substance‑use services.
Who it's for
Adults with a substance use disorder who have been released from incarceration in Riverside or Alameda Counties.
What's involved
Participants may receive a client‑centered planning session, a peer mentor, incentives for using services, and a mobile app (GeoPass), while a control group receives usual care only. All participants have study visits and questionnaires.
Time commitment
The study follows participants for up to 12 months with visits and assessments at the start, around 6 months, and at 12 months.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 59, men only. Healthy volunteers may be eligible.

You may be able to join if

  • RCT Participants
  • Assigned male at birth
  • Ages 18 - 59
  • Was released from incarceration in the previous 12 months (incarceration is defined as a stay in jail, prison, or detention centers for over 24 hours)
  • Reports an SUD diagnosis or seeking SUD services at any time in the 24 months prior to enrollment

You likely can't join if

  • Does not have a smart phone and is not willing to obtain one
  • Is not able to speak and understand English
  • Has insufficient reading skills to operate a mobile application on a cell phone CBO participating in implementation interviews \- n/a
See the full eligibility criteria
Who can join
  • RCT Participants
  • Assigned male at birth
  • Ages 18 - 59
  • Was released from incarceration in the previous 12 months (incarceration is defined as a stay in jail, prison, or detention centers for over 24 hours)
  • Reports an SUD diagnosis or seeking SUD services at any time in the 24 months prior to enrollment
  • Reports intercourse with a person assigned male at birth
  • Reports injection drug use
  • Has not received an HIV diagnosis (based on self-report)
  • Possesses a smartphone or plans to obtain one
  • Plans to reside within designated jurisdictions (counties) for the 9 months following enrollment CBO and agency staff participating in implementation surveys or interviews
  • \>=18 years of age
  • Employed at a study site or otherwise involved with intervention implementation and/or maintenance OR works at an agency in the counties where the study is taking place (Los Angeles, Riverside, San Bernardino, and...
  • Willing to provide informed consent for participation.
What rules you out
  • Does not have a smart phone and is not willing to obtain one
  • Is not able to speak and understand English
  • Has insufficient reading skills to operate a mobile application on a cell phone CBO participating in implementation interviews \- n/a

The study team makes the final eligibility decision.

Where it is enrolling

  • Oakland, California, United States
  • Riverside, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling male, 18 years to 59 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Oakland, California, United States; Riverside, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.